Clinical Trial Update: A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind, parallel-group, vehicle-controlled study comparing three Imiquimod 5% cream regimens to assess therapeutic equivalence in acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Imiquimod Cream 5% (imiquimod)

Snippet

Sponsor: Apotex Inc. | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED